Further multicenter studies should validate predictive models and refine imaging criteria for axillary response assessment.<h4>Key points</h4>QuestionIdentifying predictive factors for axillary pCR in HER2+ breast cancer patients undergoing NAC. The gene discussed is ERBB2; the disease is breast carcinoma.